Generation, characterization and structural data of chymase binding proteins based on the human Fyn kinase SH3 domain

References

• Shea-Donohue T, Stiltz J, Zhao A, Notari L. Mast cells. Curr Gastroenterol Rep 2010; 12:349 - 57; http://dx.doi.org/10.1007/s11894-010-0132-1; PMID: 20711694
   PubMedGoogle Scholar
• Miller HRP, Pemberton AD. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002; 105:375 - 90; http://dx.doi.org/10.1046/j.1365-2567.2002.01375.x; PMID: 11985658
   PubMed Web of Science ®Google Scholar
• de Garavilla L, Greco MN, Sukumar N, Chen Z-W, Pineda AO, Mathews FS, et al. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo. J Biol Chem 2005; 280:18001 - 7; http://dx.doi.org/10.1074/jbc.M501302200; PMID: 15741158
   PubMed Web of Science ®Google Scholar
• Takai S, Jin D, Miyazaki M. New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage. J Pharmacol Sci 2010; 113:301 - 9; http://dx.doi.org/10.1254/jphs.10R05FM; PMID: 20675958
   PubMed Web of Science ®Google Scholar
• Maryanoff BE, de Garavilla L, Greco MN, Haertlein BJ, Wells GI, Andrade-Gordon P, et al. Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation. Am J Respir Crit Care Med 2010; 181:247 - 53; http://dx.doi.org/10.1164/rccm.200904-0627OC; PMID: 19875688
   PubMed Web of Science ®Google Scholar
• Takai S, Jin D, Sakaguchi M, Katayama S, Muramatsu M, Sakaguchi M, et al. A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J Pharmacol Exp Ther 2003; 305:17 - 23; http://dx.doi.org/10.1124/jpet.102.045179; PMID: 12649348
   PubMed Web of Science ®Google Scholar
• Doggrell SA, Wanstall JC. Cardiac chymase: pathophysiological role and therapeutic potential of chymase inhibitors. Can J Physiol Pharmacol 2005; 83:123 - 30; http://dx.doi.org/10.1139/y04-136; PMID: 15791285
   PubMed Web of Science ®Google Scholar
• Diaconu NC, Rummukainen J, Naukkarinen A, Mättö M, Harvima RJ, Pelkonen J, et al. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro. Arch Dermatol Res 2011; 303:499 - 512; http://dx.doi.org/10.1007/s00403-011-1121-4; PMID: 21274549
   PubMed Web of Science ®Google Scholar
• Griffin L, Lawson A. Antibody fragments as tools in crystallography. Clin Exp Immunol 2011; 165:285 - 91; http://dx.doi.org/10.1111/j.1365-2249.2011.04427.x; PMID: 21649648
   PubMed Web of Science ®Google Scholar
• Iwata S, Ostermeier C, Ludwig B, Michel H. Structure at 2.8 A resolution of cytochrome c oxidase from Paracoccus denitrificans. Nature 1995; 376:660 - 9; http://dx.doi.org/10.1038/376660a0; PMID: 7651515
   PubMed Web of Science ®Google Scholar
• Skerra A. Engineered protein scaffolds for molecular recognition. J Mol Recognit 2000; 13:167 - 87; http://dx.doi.org/10.1002/1099-1352(200007/08)13:4<167::AID-JMR502>3.0.CO;2-9; PMID: 10931555
   PubMed Web of Science ®Google Scholar
• Binz HK, Plückthun A. Engineered proteins as specific binding reagents. Curr Opin Biotechnol 2005; 16:459 - 69; http://dx.doi.org/10.1016/j.copbio.2005.06.005; PMID: 16005204
   PubMed Web of Science ®Google Scholar
• Gebauer M, Skerra A. Engineered protein scaffolds as next-generation antibody therapeutics. Curr Opin Chem Biol 2009; 13:245 - 55; http://dx.doi.org/10.1016/j.cbpa.2009.04.627; PMID: 19501012
   PubMed Web of Science ®Google Scholar
• Musacchio A, Wilmanns M, Saraste M. Structure and function of the SH3 domain. Prog Biophys Mol Biol 1994; 61:283 - 97; http://dx.doi.org/10.1016/0079-6107(94)90003-5; PMID: 8073124
   PubMed Web of Science ®Google Scholar
• Grabulovski D, Kaspar M, Neri DA. A novel, non-immunogenic Fyn SH3-derived binding protein with tumor vascular targeting properties. J Biol Chem 2007; 282:3196 - 204; http://dx.doi.org/10.1074/jbc.M609211200; PMID: 17130124
   PubMed Web of Science ®Google Scholar
• Bertschinger J, Grabulovski D, Neri D. Selection of single domain binding proteins by covalent DNA display. Protein Eng Des Sel 2007; 20:57 - 68; http://dx.doi.org/10.1093/protein/gzl055; PMID: 17242027
   PubMed Web of Science ®Google Scholar
• Viti F, Nilsson F, Demartis S, Huber A, Neri D. Design and use of phage display libraries for the selection of antibodies and enzymes. Methods Enzymol 2000; 326:480 - 505; http://dx.doi.org/10.1016/S0076-6879(00)26071-0; PMID: 11036659
   PubMed Web of Science ®Google Scholar
• Semba K, Nishizawa M, Miyajima N, Yoshida MC, Sukegawa J, Yamanashi Y, et al. yes-related protooncogene, syn, belongs to the protein-tyrosine kinase family. Proc Natl Acad Sci U S A 1986; 83:5459 - 63; http://dx.doi.org/10.1073/pnas.83.15.5459; PMID: 3526330
   PubMed Web of Science ®Google Scholar
• Kawakami T, Pennington CY, Robbins KC. Isolation and oncogenic potential of a novel human src-like gene. Mol Cell Biol 1986; 6:4195 - 201; PMID: 3099169
   PubMed Web of Science ®Google Scholar
• Silacci M, Brack S, Schirru G, Mårlind J, Ettorre A, Merlo A, et al. Design, construction, and characterization of a large synthetic human antibody phage display library. Proteomics 2005; 5:2340 - 50; http://dx.doi.org/10.1002/pmic.200401273; PMID: 15880779
   PubMed Web of Science ®Google Scholar
• De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J, et al. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A 2006; 103:4586 - 91; http://dx.doi.org/10.1073/pnas.0505379103; PMID: 16537393
   PubMed Web of Science ®Google Scholar
• Sennhauser G, Grütter MG. Chaperone-assisted crystallography with DARPins. Structure 2008; 16:1443 - 53; http://dx.doi.org/10.1016/j.str.2008.08.010; PMID: 18940601
   PubMed Web of Science ®Google Scholar
• Monroe N, Sennhauser G, Seeger MA, Briand C, Grütter MG. Designed ankyrin repeat protein binders for the crystallization of AcrB: plasticity of the dominant interface. J Struct Biol 2011; 174:269 - 81; http://dx.doi.org/10.1016/j.jsb.2011.01.014; PMID: 21296164
   PubMed Web of Science ®Google Scholar
• Abskharon RNN, Soror SH, Pardon E, El Hassan H, Legname G, Steyaert J, et al. Combining in-situ proteolysis and microseed matrix screening to promote crystallization of PrPc-nanobody complexes. Protein Eng Des Sel 2011; 24:737 - 41; http://dx.doi.org/10.1093/protein/gzr017; PMID: 21536542
   PubMed Web of Science ®Google Scholar
• Steyaert J, Kobilka BK. Nanobody stabilization of G protein-coupled receptor conformational states. Curr Opin Struct Biol 2011; 21:567 - 72; http://dx.doi.org/10.1016/j.sbi.2011.06.011; PMID: 21782416
   PubMed Web of Science ®Google Scholar
• Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res 1991; 19:4133 - 7; http://dx.doi.org/10.1093/nar/19.15.4133; PMID: 1908075
   PubMed Web of Science ®Google Scholar
• Perspicace S, Banner D, Benz J, Müller F, Schlatter D, Huber W. Fragment-based screening using surface plasmon resonance technology. J Biomol Screen 2009; 14:337 - 49; http://dx.doi.org/10.1177/1087057109332595; PMID: 19403917
   PubMed Web of Science ®Google Scholar
• Kabsch W. XDS. Acta Crystallogr D Biol Crystallogr 2010; 66:125 - 32; http://dx.doi.org/10.1107/S0907444909047337; PMID: 20124692
   PubMed Web of Science ®Google Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr 2007; 40:658 - 74; http://dx.doi.org/10.1107/S0021889807021206; PMID: 19461840
   PubMed Web of Science ®Google Scholar
• Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997; 53:240 - 55; http://dx.doi.org/10.1107/S0907444996012255; PMID: 15299926
   PubMed Web of Science ®Google Scholar
• Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994; 50:760 - 3; http://dx.doi.org/10.1107/S0907444994003112; PMID: 15299374
   PubMed Web of Science ®Google Scholar
• Bricogne G. Direct phase determination by entropy maximization and likelihood ranking: status report and perspectives. Acta Crystallogr D Biol Crystallogr 1993; 49:37 - 60; http://dx.doi.org/10.1107/S0907444992010400; PMID: 15299544
   PubMed Web of Science ®Google Scholar
• Roversi P, Blanc E, Vonrhein C, Evans G, Bricogne G. Modelling prior distributions of atoms for macromolecular refinement and completion. Acta Crystallogr D Biol Crystallogr 2000; 56:1316 - 23; http://dx.doi.org/10.1107/S0907444900008490; PMID: 10998628
   PubMed Web of Science ®Google Scholar
• Blanc E, Roversi P, Vonrhein C, Flensburg C, Lea SM, Bricogne G. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr D Biol Crystallogr 2004; 60:2210 - 21; http://dx.doi.org/10.1107/S0907444904016427; PMID: 15572774
   PubMed Web of Science ®Google Scholar
• Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 2010; 66:213 - 21; http://dx.doi.org/10.1107/S0907444909052925; PMID: 20124702
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004; 60:2126 - 32; http://dx.doi.org/10.1107/S0907444904019158; PMID: 15572765
   PubMed Web of Science ®Google Scholar